Abstract
The study of human growth hormone isoforms has conduced to the elaboration of patents related to very important items: codifying and regulatory sequences, production of the protein at large-scale, modifications to prolong half-life as monomer, dimer and fusion protein for treatments directed to growth-associated diseases. The designed methodologies directed to the identification and quantification of hGH are beside the formers establishing very important basis of patented sources that can be used for a specific and opportune diagnosis and treatment of biological abnormalities or undesirable effects when these growth hormones are involved.
Keywords: Growth hormone isoforms, modified growth hormone, growth hormone-related peptides, growth hormone detection, acetylable chromatin, coactivator complexes, GH-N promoter, proximal promoter regions, Locus Control Region (LCR), peripheral blood monocyte cells (PBMCs), hGH-N polypeptides, disulfide bridges, transgenic mice, dimerization, acid-labile subunit
20